Steve Leung

机构：NHS Lothian, University of Kentucky

发表论文 33 篇 · 总被引 241 次 · h-index 8

代表论文

• A Phase II study of neoadjuvant axitinib for reducing the extent of venous tumour thrombus in clear cell renal cell cancer with venous invasion (NAXIVA) (2022 · British Journal of Cancer · 被引 68)
• Impact of COVID-19 on Cardiovascular Testing in the United States Versus the Rest of the World (2021 · JACC. Cardiovascular imaging · 被引 39)
• A Simple Clinical Tool for Stratifying Risk of Clinically Significant CKD after Nephrectomy: Development and Multinational Validation (2020 · Journal of the American Society of Nephrology · 被引 23)
• Leibovich score is the optimal clinico-pathological system associated with recurrence of non-metastatic clear cell renal cell carcinoma (2021 · Urologic Oncology Seminars and Original Investigations · 被引 18)
• Impact of COVID-19 Pandemic on Cardiovascular Testing in Asia (2021 · JACC Asia · 被引 13)
• Real world outcomes of biopsy‐proven oncocytic neoplasm of the kidney managed by surveillance (2022 · BJUI Compass · 被引 8)